A detailed history of Franklin Resources Inc transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 19,561 shares of XERS stock, worth $68,659. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,561
Previous 19,561 -0.0%
Holding current value
$68,659
Previous $55,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.06 - $2.96 $150 - $216
73 Added 0.37%
19,561 $55,000
Q2 2024

Aug 14, 2024

BUY
$1.7 - $2.45 $33,129 - $47,745
19,488 New
19,488 $43,000
Q2 2023

Aug 11, 2023

BUY
$1.82 - $2.98 $115,939 - $189,834
63,703 New
63,703 $166,000

Others Institutions Holding XERS

About Xeris Biopharma Holdings, Inc.


  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $477M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.